Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8099
-0.0201 (-2.42%)
Mar 11, 2026, 1:22 PM EDT - Market open
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $29.31 million as of March 11, 2026. Its market cap has decreased by -28.17% in one year.
Market Cap
29.31M
Enterprise Value
26.16M
1-Year Change
-28.17%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $29.31M, a decrease of -69.08%. That is a compound annual growth rate of -15.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 30.00M | -11.76% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 32.08M |
| CEL-SCI | 31.00M |
| Lantern Pharma | 30.70M |
| Cue Biopharma | 30.53M |
| RenovoRx | 30.31M |
| Evaxion | 30.14M |
| Tevogen Bio Holdings | 29.76M |
| Kyntra Bio | 29.21M |